281 related articles for article (PubMed ID: 18466179)
1. Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype.
Galel SA; Webster J; Roa L
Transfusion; 2008 Jul; 48(7):1486-94. PubMed ID: 18466179
[TBL] [Abstract][Full Text] [Related]
2. Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay.
Pai A; Kleinman S; Malhotra K; Lee-Haynes L; Pietrelli L; Saldanha J
Transfusion; 2008 Oct; 48(10):2184-9. PubMed ID: 18694466
[TBL] [Abstract][Full Text] [Related]
3. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
Kleinman S; Glynn SA; Busch M; Todd D; Powell L; Pietrelli L; Nemo G; Schreiber G; Bianco C; Katz L;
Transfusion; 2005 Apr; 45(4):469-79. PubMed ID: 15819665
[TBL] [Abstract][Full Text] [Related]
4. West Nile virus in Canadian blood donors.
Cameron C; Reeves J; Antonishyn N; Tilley P; Alport T; Eurich B; Towns D; Lane D; Saldanha J
Transfusion; 2005 Apr; 45(4):487-91. PubMed ID: 15819667
[TBL] [Abstract][Full Text] [Related]
5. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.
Busch MP; Tobler LH; Saldanha J; Caglioti S; Shyamala V; Linnen JM; Gallarda J; Phelps B; Smith RI; Drebot M; Kleinman SH
Transfusion; 2005 Apr; 45(4):492-9. PubMed ID: 15819668
[TBL] [Abstract][Full Text] [Related]
6. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.
Custer B; Tomasulo PA; Murphy EL; Caglioti S; Harpool D; McEvoy P; Busch MP
Transfusion; 2004 Nov; 44(11):1547-54. PubMed ID: 15504158
[TBL] [Abstract][Full Text] [Related]
7. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
Tobler LH; Bianco C; Glynn SA; Schreiber GB; Dille BJ; Prince HE; Lanciotti RS; Linnen JM; Gallarda J; Shyamala V; Smith D; Kleinman SH; Busch MP;
Transfusion; 2005 Apr; 45(4):480-6. PubMed ID: 15819666
[TBL] [Abstract][Full Text] [Related]
8. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
Busch MP; Caglioti S; Robertson EF; McAuley JD; Tobler LH; Kamel H; Linnen JM; Shyamala V; Tomasulo P; Kleinman SH
N Engl J Med; 2005 Aug; 353(5):460-7. PubMed ID: 16079369
[TBL] [Abstract][Full Text] [Related]
9. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.
Biggerstaff BJ; Petersen LR
Transfusion; 2009 Jun; 49(6):1151-9. PubMed ID: 19309472
[TBL] [Abstract][Full Text] [Related]
10. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.
Kleinman SH; Williams JD; Robertson G; Caglioti S; Williams RC; Spizman R; Morgan L; Tomasulo P; Busch MP
Transfusion; 2009 Jun; 49(6):1160-70. PubMed ID: 19320866
[TBL] [Abstract][Full Text] [Related]
11. West Nile virus blood transfusion-related infection despite nucleic acid testing.
Macedo de Oliveira A; Beecham BD; Montgomery SP; Lanciotti RS; Linnen JM; Giachetti C; Pietrelli LA; Stramer SL; Safranek TJ
Transfusion; 2004 Dec; 44(12):1695-9. PubMed ID: 15584982
[TBL] [Abstract][Full Text] [Related]
12. West Nile virus among blood donors in the United States, 2003 and 2004.
Stramer SL; Fang CT; Foster GA; Wagner AG; Brodsky JP; Dodd RY
N Engl J Med; 2005 Aug; 353(5):451-9. PubMed ID: 16079368
[TBL] [Abstract][Full Text] [Related]
13. West Nile virus transmission through blood transfusion--South Dakota, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(4):76-9. PubMed ID: 17268405
[TBL] [Abstract][Full Text] [Related]
14. Detection of West Nile virus in blood donations--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(32):769-72. PubMed ID: 12917583
[TBL] [Abstract][Full Text] [Related]
15. West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic.
Francis RO; Strauss D; Williams JD; Whaley S; Shaz BH
Transfusion; 2012 Dec; 52(12):2664-70. PubMed ID: 22486471
[TBL] [Abstract][Full Text] [Related]
16. Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(13):281-4. PubMed ID: 15071426
[TBL] [Abstract][Full Text] [Related]
17. Reacting to an emerging safety threat: West Nile virus in North America.
Stramer SL
Dev Biol (Basel); 2007; 127():43-58. PubMed ID: 17486880
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-associated transmission of West Nile virus--Arizona, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(36):842-4. PubMed ID: 15371966
[TBL] [Abstract][Full Text] [Related]
19. Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors.
Orton SL; Stramer SL; Dodd RY
Transfusion; 2006 Feb; 46(2):272-7. PubMed ID: 16441606
[TBL] [Abstract][Full Text] [Related]
20. West Nile virus in 2006 and 2007: the Canadian Blood Services' experience.
O'Brien SF; Scalia V; Zuber E; Hawes G; Alport EC; Goldman M; Fearon MA
Transfusion; 2010 May; 50(5):1118-25. PubMed ID: 20051051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
